Type 1 Diabetes Reversed by Integrating Mesenchymal Stem Cells.

MSCs and HCELL molecules track down islet cells and reverse inflammation.

According to a recently published study from the Brigham and Woman’s Hospital, mesenchymal stem cells [MSCs] have the ability to reverse type I diabetes by suppressing the auto-immune attack of islet cells.  Although the MSCs cannot be directly injected into the pancreas, the researchers utilized the surface adhesion molecule HCELL to hone the stem cells in on the inflamed islets, allowing them to normalize blood sugar levels without the use of insulin.

While several therapies aim to treat the symptoms of type 1 diabetes, the disease currently has no cure.  The application of mesenchymal stem cells in conjunction with HCELL’s ability to direct the MSCs to the islets could present an important breakthrough towards treating the actual cause of the disease.  With further research, stem cells may provide the first therapy that addresses type I diabetes at the source, providing patients with a higher quality of life.

The BWH’s research is an example of the potential for stem cell regenerative medical therapies to effectively treat seemingly intractable and incurable conditions. To learn more about stem cells and how to insure immediate access to emerging personalized regenerative treatments by banking your own valuable stem cells, please visit StemSave or call 877-783-6728 (877- StemSave) today.

 

 

To view the full article, click here.

 

 

The Future of Regenerative Medicine is Now™.